Profile
Kala Subramanian is Senior Vice President-Development & Operations at CRISPR Therapeutics AG. In the past Dr. Subramanian was VP & Global Head-Strategic Development at Novartis Pharmaceuticals Corp. and Senior Project Manager at Takeda Oncology Co. She received a doctorate from Cornell University and a graduate degree from Indian Institute of Technology Madras.
Kala Subramanian active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/09/2021 |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Corporate Officer/Principal | 01/05/2019 |
Abiologicsb LLC
Abiologicsb LLC BiotechnologyHealth Technology Operates as a biotech company that develops programmable biologic medicines using AI and advanced chemical synthesis | Founder | 01/01/2021 |
Former positions of Kala Subramanian
| Companies | Position | End |
|---|---|---|
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Founder | 15/07/2026 |
| CRISPR THERAPEUTICS AG | Chief Operating Officer | 01/04/2018 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/06/2016 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/12/2003 |
Training of Kala Subramanian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology Madras
Indian Institute of Technology Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Health Technology |
Abiologicsb LLC
Abiologicsb LLC BiotechnologyHealth Technology Operates as a biotech company that develops programmable biologic medicines using AI and advanced chemical synthesis | Health Technology |
- Stock Market
- Insiders
- Kala Subramanian
















